Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database - Takeaways - MDSpire

Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database

  • By

  • Noah C. Wilson

  • Danielle B. Dilsaver

  • Ryan W. Walters

  • Kalyana C. Nandipati

  • February 27, 2024

  • 0 min

Share

  • 1

    Obesity affects over 40% of American adults, significantly increasing the risk of various health complications.

  • 2

    Approximately one-third of patients with inflammatory bowel disease (IBD) also suffer from obesity.

  • 3

    Bariatric surgery, particularly sleeve gastrectomy, is a primary treatment for obesity, showing better outcomes than nonsurgical methods.

  • 4

    The study utilizes the Nationwide Readmissions Database to assess post-operative outcomes for sleeve gastrectomy in IBD patients.

  • 5

    Key outcomes analyzed include in-hospital mortality, post-operative complications, and 90-day readmission rates for patients with and without IBD.

Original Source(s)

Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database

  • by Noah C. Wilson, Danielle B. Dilsaver, Ryan W. Walters, Kalyana C. Nandipati

  • February 27, 2024

Related Content

Risk factors for postoperative adverse outcomes in patients with high anal fistula undergoing modified TROPIS procedure combined with Parks’ fistulotomy with seton: a retrospective study

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

Effect of bariatric surgery on matrix metalloproteinase activity in patients with morbid obesity